The recent development of next generation microarrays will offer the opportunity to include strain specific markers (pathogenicity islands) of common P. aeruginosa clones.
We describe the development of a next-generation microarray based on the new highly-efficient Affymetrix Axiom genotyping technology that we are using to genotype individuals of European ancestry from the Kaiser Permanente Research Program on Genes, Environment and Health (RPGEH).
In this study, we used a higher-resolution genome-wide screening (next-generation microarrays) comprising 963,331 human sequences (3 kb spacing between probes) for whole genome DNA variation analysis.
This article outlines recent advances in several key areas capable of enhancing this field including: organ culture, genetic engineering, next generation sequencing, microarray technology, and novel molecular imaging techniques.
We provide several examples of how these concepts are applied in next generation sequencing and microarray data.
This combination of next generation sequencing and microarray generation will be particularly valuable for non-model species for which genomic information is limited.
The TCGA CRC project relied on a combination of next generation sequencing and microarray genomic platforms to characterize different CRC genetic aberration features and the individual affected genes.
Methods should include those used to obtain nucleic acids (e.g. PCR, capture, whole genome amplification) as well as those to analyze the nucleic acids (e.g. bi-directional Sanger sequencing, next generation sequencing, chromosomal microarray, genotyping technologies, etc).
We conclude that the barcodes of the barFLEX collection are suitable for analysis using either next generation sequencing or microarrays.
Recently developed molecular methods (e.g., next generation sequencing and microarrays) have been applied to investigate the genome and transcriptome characteristics of HAB-forming species [ 16, 18, 20– 23].
